Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1488250

Cover Image

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1488250

Coronary Artery Bypass Graft Market - By Method (Traditional (On-pump), Minimally Invasive Direct), Surgery Type (Single, Double, Triple, Quadruple), Product (Grafts, Retractors, Heart Positioner), End-use - Global Forecast 2024 - 2032

PUBLISHED:
PAGES: 210 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 4850
PDF & Excel (Multi User License)
USD 5350
PDF & Excel (Enterprise User License)
USD 8350

Add to Cart

Global Coronary Artery Bypass Graft Market Size will witness 6.8% CAGR between 2024 and 2032 due to increasing recognition from leading hospitals and associations. CABG procedures, a cornerstone of cardiac surgery, are witnessing a rise in demand globally. Leading hospitals are recognizing the efficacy and long-term benefits of CABG in treating coronary artery disease. For instance, in June 2023, The Society of Thoracic Surgeons (STS) awarded Kettering Health Dayton with a prestigious three-star rating for its exceptional patient care and outcomes in isolated coronary artery bypass grafting surgery. This distinguished rating positioned Kettering Health Dayton among the top tier of quality providers in both the United States and Canada for heart bypass surgery.

Moreover, associations and medical bodies are advocating for CABG as a preferred option for patients with complex coronary artery disease. This recognition is driving the demand for CABG procedures and associated products, including grafts and devices. As a result, the CABG market is experiencing steady growth, with projections indicating further expansion. This trend underscores the importance of CABG in addressing cardiovascular health, ensuring a healthier future for patients worldwide.

The overall Coronary Artery Bypass Graft Industry is classified based on the method, surgery type, product, end-use, and region.

The traditional (on-pump) CABG segment will undergo sizeable growth from 2024 to 2032. Despite the emergence of minimally invasive techniques, traditional CABG remains a cornerstone in treating coronary artery disease. Its effectiveness and long-standing success in restoring blood flow to the heart make it a preferred choice for many patients and physicians. As a result, there is a sustained demand for CABG procedures and associated products, driving CABG market growth. This demand underscores the continued relevance and importance of traditional CABG in cardiovascular medicine.

The coronary artery bypass graft market share from the single CABG surgery segment will register a notable CAGR from 2024 to 2032. Single CABG, also known as isolated CABG, involves bypassing a single blocked coronary artery, providing targeted treatment for patients with specific cardiovascular issues. This procedure offers reduced surgical risk and faster recovery than multiple bypass surgeries, making it an increasingly preferred option. As a result, there is a notable demand for single CABG surgeries and associated products, contributing to the growth of the CABG market. This demand highlights the importance of tailored treatment options in addressing coronary artery disease effectively.

Coronary artery bypass graft market from Asia Pacific will showcase a commendable CAGR from 2024 to 2032. Rapid urbanization, changing lifestyles, and an aging population contribute to the increasing prevalence of coronary artery disease in the region. Rising healthcare expenditure and improving access to advanced medical technologies further drive the demand for CABG procedures. Additionally, growing awareness about cardiovascular health and the adoption of Westernized diets lead to a higher demand for CABG surgeries. Consequently, the Asia-Pacific region witnesses significant growth in the CABG market, reflecting the region's increasing focus on addressing cardiovascular health issues.

Product Code: 8564

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Base estimates & calculations
  • 1.3 Data collection
  • 1.4 Forecast parameters
  • 1.5 Data validation
  • 1.6 Data sources
    • 1.6.1 Primary
    • 1.6.2 Secondary
      • 1.6.2.1 Paid sources
      • 1.6.2.2 Public sources

Chapter 2 Executive Summary

  • 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing in prevalence of cardiovascular diseases
      • 3.2.1.2 Growing technological advancement
      • 3.2.1.3 Rising prevalence of hypertension
      • 3.2.1.4 Favorable reimbursement scenario
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High cost associated with surgery procedures
      • 3.2.2.2 Complications associated with the surgery
  • 3.3 Growth potential analysis
  • 3.4 Technological landscape
  • 3.5 Regulatory landscape
  • 3.6 Porter's analysis
    • 3.6.1 Supplier power
    • 3.6.2 Buyer power
    • 3.6.3 Threat of new entrants
    • 3.6.4 Threat of substitutes
    • 3.6.5 Industry rivalry
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Competitive positioning matrix
  • 4.4 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Method, 2018 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Traditional (on-pump) CABG
  • 5.3 Minimally invasive direct CABG
    • 5.3.1 Off-pump CABG
    • 5.3.2 Keyhole CABG
    • 5.3.3 Other minimally invasive CABG surgery types

Chapter 6 Market Estimates and Forecast, By Surgery Type, 2018 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Single CABG surgery
  • 6.3 Double CABG surgery
  • 6.4 Triple CABG surgery
  • 6.5 Quadruple CABG surgery

Chapter 7 Market Estimates and Forecast, By Product, 2018 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Grafts
    • 7.2.1 Saphenous vein grafts
    • 7.2.2 Internal thoracic artery grafts
    • 7.2.3 Other grafts
  • 7.3 Retractors
  • 7.4 Heart positioners
  • 7.5 Tissue stabilizers
  • 7.6 Other products

Chapter 8 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospitals
  • 8.3 Cardiology centers
  • 8.4 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Argentina
    • 9.5.3 Mexico
    • 9.5.4 Rest of Latin America
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE
    • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

  • 10.1 Edwards Lifesciences Corporation
  • 10.2 Getinge AB
  • 10.3 Genesee Biomedical
  • 10.4 Guidant Corporation
  • 10.5 LivaNova PLC
  • 10.6 Medtronic plc
  • 10.7 Novadaq Technologies Inc.
  • 10.8 Stryker Corporation
  • 10.9 Teleflex Incorporated
  • 10.10 Terumo Corporation
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!